Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Circle8 Group, Inc.

Circle8 Group, Inc. (CIRC) Stock Overview

Explore Circle8 Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CIRC●NASDAQ
HealthcareMedical - Pharmaceuticals
$0.72
$0.05(6.42%)
U.S. Market opens in 16h 39m

Circle8 Group, Inc. (CIRC)

Meyka AI Score

Z

Key Financials

Market Cap64.7M
P/E RatioN/A
EPS (TTM)$-0.44
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$0.51
3 Months$0.00
1 Year Target$0.00

CIRC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Circle8 Group, Inc. (CIRC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 64.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-6.42%
5-Day Change
-6.65%
1-Month Change
63.36%
3-Month Change
-6.89%
6-Month Change
-6.89%
Year-to-Date (YTD) Change
-6.89%
1-Year Change
-6.89%
3-Year Change
-6.89%
5-Year Change
-6.89%
All-Time (Max) Change
-6.89%

Contact Information

https://www.circle8group.com
31 30 600 150
270 Sylvan Avenue, Suite 2230, Englewood Cliffs, NJ, 07632

Company Facts

3,000 Employees
IPO DateAug 27, 2021
CountryUS
Actively Trading

Frequently Asked Questions